课题基金 / 基金详情

Innate immunity and dendritic cells in cryptosporidiosis

Innate immunity and dendritic cells in cryptosporidiosis
隐孢子虫病中的先天免疫和树突状细胞
批准号:
7272680
负责人:
SAUL r TZIPORI
金额:
$41.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-15 至 2011-07-31

项目摘要

项目成果

SAUL r TZIPORI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application is in response to RFA-AI-05-042 on Innate Immunity to Category B protozoa of which Cryptosporidium spp rank among the most significant. Two species, C. hominis and C. parvum, are linked with human cryptosporidiosis, a serious cause of morbidity and mortality worldwide, and against which there is no effective therapy of prevention. Our goal is to elucidate the mechanisms by which immune cells initiate resistance against cryptosporidiosis with a view that a better understanding of the various components of the immune response will lead to development of effective vaccines and adjuvants to combat the infection in humans. Our central hypothesis is that dendritic cells recognize Cryptosporidium through Toll like receptor(s) which initiate the process of resistance against parasite invasion. We base this on the observations that: 1) dendritic cells sense pathogens through Toll-like receptors which lead to the initiation of adoptive immune responses, 2) proinflammatory cytokine IL-12, predominately produced by dendritic cells, is critical in controlling Cryptosporidium infection, and 3) bone marrow-derived CD40-positive cells are required for mice to clear C. parvum infection. Based on these observations, the specific aims are designed to investigate the innate immune response to cryptosporidiosis with a view to determining the mechanisms of Toll-like receptor signaling that lead to such responses, using both mice and human dendritic cells. The specific aims are to: 1) characterize the role of mouse dendritic cells in the innate immune response against C. parvum infection; 2) determine the nature of activation of human dendritic cells upon infection with C. parvum or C. hominis; 3) identify the Toll-like receptor used by Cryptosporidium and isolate TLR activating ligand(s) expressed by the parasite. The proposed studies will provide the basis for understanding the mechanisms of innate immune recognition and response to parasite invasion necessary for future design of vaccines and other methods of interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF INNATE IMMUNITY TO ENTEROCYTOZOON BIENEUSI INFECTION
  • 批准号:
    7958373
  • 项目类别:
  • 资助金额:
    $11.19万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
Development of Aptamer-Based Therapy Against HUS
  • 批准号:
    7644745
  • 项目类别:
  • 资助金额:
    $68.11万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
Development of Aptamer-Based Therapy Against HUS
  • 批准号:
    7929518
  • 项目类别:
  • 资助金额:
    $66.47万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
INNATE IMMUNITY OF ENTEROCYTOZOON BIENEUSI (EB) IN VIVO
  • 批准号:
    7715540
  • 项目类别:
  • 资助金额:
    $5.52万
  • 财政年份:
    2008
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
海外基金